Bristol City come within inches of an immediate equaliser from a corner of their own. The Wales centre-back finds space at ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

Given its better valuation, we believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pick than its peer – ...

Kyle Larson shut down fan outrage for the lack of excitement during last Sunday’s Round of 16 race at Bristol in a lengthy X ...

Agonisingly for England, the clouds did not dump their load until Rashid had delivered four balls of the 21st, by which time ...

Australia defeated England 3-2 in their one-day international series after winning a rain-hit decider in Bristol on Sunday ...

This is a big approval for the company, given that Cobenfy doesn’t have the classic side effects seen in other antipsychotic ...

Last week's Bristol Night Race was panned as a bust, but that didn't stop some drivers in the field from enjoying the race ...

Simon Mann reflects on England’s ODI series loss to Australia. Simon Mann is alongside former England bowler Steven Finn, ...

Swansea City were denied a third straight Championship win after they were held by Bristol City in an enthralling encounter ...

After decades of stagnation in the schizophrenia field, Bristol Myers Squibb’s $14 billion deal for Karuna Therapeutics has ...

Bristol Myers obtained the drug Cobenfy, also known as KarXT, through its $14 billion takeover of Karuna Therapeutics last ...